Metreleptin for insulin resistance

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 Aug 2003: Trial started, NCT00085982
  2. 21 Jun 2004: Trial registered, NCT00085982

The trials

NCT00085982: Effect of Metreleptin Therapy in the Treatment of Severe Insulin Resistance

State
Under way
Phase
Phase 2
People
11 taking part
Started
21 Aug 2003
Primary completion
23 Oct 2019
Arms
Leptin Treatment
Results
Posted on the registry
  1. 21 Aug 2003: Trial started
  2. 21 Jun 2004: Trial registered
  3. 15 Dec 2021: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Myalept.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.